Jul 5, 2016 · Atroiza is a combination pill that contains three HIV drugs. It is a generic version of Atripla. It is mainly used to treat HIV. However, in some countries the same drugs (efavirenz/tenofovirDF/emtricitabine) are used as PEP to prevent HIV infection.

Jan 7, 2025 · Learn about Atroiza uses, dosage, side effects, food interactions, and more. Get all the details about Atroiza from MedicinesFAQ.

Jul 2, 2024 · Efavirenz/emtricitabine/tenofovir DF comes in tablet form. Each tablet contains: 600 mg efavirenz; 200 mg emtricitabine; 300 mg tenofovir disoproxil fumarate; Take efavirenz/emtricitabine/tenofovir DF according to your health care provider’s instructions.

Jun 18, 2013 · Atroiza is a generic version of Atripla. Please me know if you have any questions or I can help further.

Jun 26, 2023 · ATRIPLA ® is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.

Efavirenz/emtricitabine/tenofovir disoproxil fumarate are medications used to treat HIV. They are antiretroviral drugs combined in one pill, taken once a day. The pill combines 600mg efavirenz, 200mg emtricitabine and 245mg tenofovir disoproxil fumarate.

Mar 12, 2025 · Atripla is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). This medicine is not a cure for HIV or AIDS. Atripla is for use in adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

Efavirenz/emtricitabine/tenofovir, sold under the brand name Atripla among others, is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. [7][6] It contains efavirenz, emtricitabine, and tenofovir disoproxil. [7][6] It can be used by itself or together with other antiretroviral medications. [7] .

Dec 13, 2013 · Atroiza contains a drug called efavirenz which has side effects that include sleep disturbance, mood changes and headaches. Usually these will improve over the first few weeks of treatment. However, some people change to a different drug because of these side effects.

Efavirenz is a non-competitive inhibitor of HIV-1 reverse transcriptase (RT) and does not significantly inhibit HIV-2 RT or cellular DNA polymerases (α, β, γ or δ). Emtricitabine is a synthetic nucleoside analogue of cytidine with activity that is specific to HIV-1, HIV-2 and HBV.